204 related articles for article (PubMed ID: 16783876)
1. Primary hyperaldosteronism associated with hypertensive emergencies.
Labinson PT; White WB; Tendler BE; Mansoor GA
Am J Hypertens; 2006 Jun; 19(6):623-7. PubMed ID: 16783876
[TBL] [Abstract][Full Text] [Related]
2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
4. Primary aldosteronism: a new insight into pathogenesis, diagnosis, and treatment in hypertensive patients.
Hyla-Klekot L; Kokot F
Pol Arch Med Wewn; 2013; 123(10):547-51. PubMed ID: 24104388
[TBL] [Abstract][Full Text] [Related]
5. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
Reincke M
MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
[No Abstract] [Full Text] [Related]
6. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
7. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
Oelkers W; Diederich S; Bähr V
J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
[TBL] [Abstract][Full Text] [Related]
8. Primary aldosteronism: diagnostic and therapeutic considerations.
Nishizaka MK; Calhoun DA
Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of renal vascular hypertension and primary hyperaldosteronism.
Calif Med; 1971 Dec; 115(6):40-7. PubMed ID: 5132525
[No Abstract] [Full Text] [Related]
10. Diagnosis of secondary forms of hypertension. A comprehensive protocol.
Grim CE; Weinberger MH; Higgins JT; Kramer NJ
JAMA; 1977 Mar; 237(13):1331-5. PubMed ID: 576478
[TBL] [Abstract][Full Text] [Related]
11. Primary Hyperaldosteronism: Approach to Diagnosis and Management.
El-Asmar N; Rajpal A; Arafah BM
Med Clin North Am; 2021 Nov; 105(6):1065-1080. PubMed ID: 34688415
[TBL] [Abstract][Full Text] [Related]
12. Hyperaldosteronism: diagnosis, lateralization, and treatment.
Harvey AM
Surg Clin North Am; 2014 Jun; 94(3):643-56. PubMed ID: 24857581
[TBL] [Abstract][Full Text] [Related]
13. Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
Swearingen AJ; Kahramangil B; Monteiro R; Krishnamurthy V; Jin J; Shin J; Siperstein A; Berber E
Surgery; 2018 Apr; 163(4):807-810. PubMed ID: 29249599
[TBL] [Abstract][Full Text] [Related]
14. An uncommon cause of leg oedema.
Naito T; Hagiya H; Nakagami F; Yamamoto K
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30665933
[No Abstract] [Full Text] [Related]
15. Hyperaldosteronism among black and white subjects with resistant hypertension.
Calhoun DA; Nishizaka MK; Zaman MA; Thakkar RB; Weissmann P
Hypertension; 2002 Dec; 40(6):892-6. PubMed ID: 12468575
[TBL] [Abstract][Full Text] [Related]
16. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
[TBL] [Abstract][Full Text] [Related]
17. [Primary hyperaldosteronisms: from diagnosis to treatment].
Wémeau JL; Mounier-Vehier C; Carnaille B; Douillard C
Presse Med; 2009 Apr; 38(4):633-42. PubMed ID: 19299107
[TBL] [Abstract][Full Text] [Related]
18. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
Riester A; Reincke M
Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
[TBL] [Abstract][Full Text] [Related]
19. The role of aldosterone antagonists in the management of resistant hypertension.
Nishizaka MK; Calhoun DA
Curr Hypertens Rep; 2005 Oct; 7(5):343-7. PubMed ID: 16157075
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.
Douma S; Petidis K; Doumas M; Papaefthimiou P; Triantafyllou A; Kartali N; Papadopoulos N; Vogiatzis K; Zamboulis C
Lancet; 2008 Jun; 371(9628):1921-6. PubMed ID: 18539224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
